Indian Pharmaceutical Company conducts Clinical Analysis for the Supplement to battle against Post COVID-19 difficulties

CEnglishHealth
Aryan Das
June 21, 2021

ImmunoSEB + ProbioSEB CSC3 for post-resolution of mild to moderate COVID-19 patients   Mumbai, Maharashtra , June 21: According to recent stats, 2.77 crores of COVID-19 sufferers were recovered from 2.88 crores cases in...

Continue Reading 0